Latest News
Web Date: January 3, 2018

A banner year for new drugs

The 46 new drugs approved in 2017 represented a 20-year peak in industry productivity
Department: Business
Keywords: Pharmaceuticals, business

Last year was a high-water mark for drug approvals, with the U.S. Food & Drug Administration green-lighting 46 new molecular entities. By mid-June, FDA had given its nod to as many new molecules as were approved in all of 2016.

The 2017 number surpassed the nearly 20-year peak reached in 2015, when drug companies pushed through 45 new products.

Cancer treatments represented just over a quarter of all new molecules approved last year, though many . . .

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society